AG
Therapeutic Areas
Greenfire Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GRN-300 | Ovarian cancer, Triple-Negative Breast Cancer (TNBC) | Phase 1 |
| PCLX-001 (via Pacylex investment) | Relapsed/Refractory Acute Myeloid Leukemia (AML), Refractory Colorectal Cancer | Phase 2 |
| M-001/M-002/M-003/M-004 (MGFB Vaccine Platform) | Melanoma, Glioma, Colorectal Cancer, Hepatocellular Carcinoma (Solid Tumors) | Preclinical |